Daxor Corp
DXR12.895USD
+0.515+4.16%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
64.27MMarket Cap
37.08P/E TTM
More Details of Daxor Corp Company
Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. It specializes in blood volume measurement technology focused on blood volume testing innovation. It markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. It has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.
Daxor Corp Info
Ticker SymbolDXR
Company nameDaxor Corp
IPO dateJul 25, 1983
CEOFeldschuh (Michael Richard)
Number of employees- -
Security typeOrdinary Share
Fiscal year-endJul 25
AddressSuite 7120
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10118
Phone12122440555
Websitehttps://www.daxor.com/
Ticker SymbolDXR
IPO dateJul 25, 1983
CEOFeldschuh (Michael Richard)
Company Executives of Daxor Corp
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Richard Feldschuh
Mr. Michael Richard Feldschuh
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
212.69K
+1.50%
Mr. Jonathan Adam Feldschuh
Mr. Jonathan Adam Feldschuh
Chief Scientific Officer, Director
Chief Scientific Officer, Director
35.91K
--
Mr. Robert J. (Bob) Michel
Mr. Robert J. (Bob) Michel
Chief Financial Officer, Chief Compliance Officer, Corporate Secretary
Chief Financial Officer, Chief Compliance Officer, Corporate Secretary
17.05K
+38.62%
Mr. Edward Feuer, CPA
Mr. Edward Feuer, CPA
Independent Director
Independent Director
1.00K
--
Mr. John Jefferies
Mr. John Jefferies
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Caleb Desrosiers, Esq.
Mr. Caleb Desrosiers, Esq.
Independent Director
Independent Director
--
--
Ms. Joy Goudie, Esq.
Ms. Joy Goudie, Esq.
Independent Director
Independent Director
--
--
Mr. Bret Shapiro
Mr. Bret Shapiro
IR Contact Officer
IR Contact Officer
--
--
Dr. Henry D. Cremisi, M.D.
Dr. Henry D. Cremisi, M.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael Richard Feldschuh
Mr. Michael Richard Feldschuh
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
212.69K
+1.50%
Mr. Jonathan Adam Feldschuh
Mr. Jonathan Adam Feldschuh
Chief Scientific Officer, Director
Chief Scientific Officer, Director
35.91K
--
Mr. Robert J. (Bob) Michel
Mr. Robert J. (Bob) Michel
Chief Financial Officer, Chief Compliance Officer, Corporate Secretary
Chief Financial Officer, Chief Compliance Officer, Corporate Secretary
17.05K
+38.62%
Mr. Edward Feuer, CPA
Mr. Edward Feuer, CPA
Independent Director
Independent Director
1.00K
--
Mr. John Jefferies
Mr. John Jefferies
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Caleb Desrosiers, Esq.
Mr. Caleb Desrosiers, Esq.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Thu, Nov 27
Updated: Thu, Nov 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Joseph Feldschuh UEO
51.22%
Feldschuh (Michael Richard)
4.27%
Feldschuh (Jonathan Adam)
1.08%
The Vanguard Group, Inc.
0.98%
Renaissance Technologies LLC
0.58%
Other
41.86%
Shareholders
Shareholders
Proportion
Joseph Feldschuh UEO
51.22%
Feldschuh (Michael Richard)
4.27%
Feldschuh (Jonathan Adam)
1.08%
The Vanguard Group, Inc.
0.98%
Renaissance Technologies LLC
0.58%
Other
41.86%
Shareholder Types
Shareholders
Proportion
Individual Investor
57.11%
Investment Advisor
1.08%
Hedge Fund
0.58%
Research Firm
0.06%
Other
41.17%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
14
102.17K
2.33%
--
2025Q3
14
102.17K
2.33%
+2.08K
2025Q2
15
100.09K
2.26%
+3.04K
2025Q1
15
97.05K
2.30%
-16.23K
2024Q4
15
106.77K
1.91%
+12.72K
2024Q3
14
94.05K
1.85%
+4.76K
2024Q2
13
89.28K
1.77%
+4.12K
2024Q1
13
85.17K
1.54%
+11.30K
2023Q4
13
73.17K
1.98%
-131.00
2023Q3
12
73.30K
2.02%
-1.71K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Joseph Feldschuh UEO
2.55M
51.22%
--
--
May 19, 2025
Feldschuh (Michael Richard)
212.69K
4.27%
+3.14K
+1.50%
May 19, 2025
Feldschuh (Jonathan Adam)
35.91K
0.72%
--
--
May 19, 2025
The Vanguard Group, Inc.
49.03K
0.98%
--
--
Jun 30, 2025
Renaissance Technologies LLC
28.02K
0.56%
-100.00
-0.36%
Jun 30, 2025
Michel (Robert J)
17.05K
0.34%
+4.75K
+38.62%
May 19, 2025
Morgan Stanley Smith Barney LLC
3.56K
0.07%
+3.47K
+3986.21%
Jun 30, 2025
Desrosiers (Caleb J.D.)
3.16K
0.06%
--
--
May 19, 2025
SBI Securities Co., Ltd.
3.13K
0.06%
--
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Daxor Corp?
The top five shareholders of Daxor Corp are:
Joseph Feldschuh UEO holds 2.55M shares, accounting for 51.22% of the total shares.
Feldschuh (Michael Richard) holds 212.69K shares, accounting for 4.27% of the total shares.
Feldschuh (Jonathan Adam) holds 35.91K shares, accounting for 0.72% of the total shares.
The Vanguard Group, Inc. holds 49.03K shares, accounting for 0.98% of the total shares.
Renaissance Technologies LLC holds 28.02K shares, accounting for 0.56% of the total shares.
Joseph Feldschuh UEO holds 2.55M shares, accounting for 51.22% of the total shares.
Feldschuh (Michael Richard) holds 212.69K shares, accounting for 4.27% of the total shares.
Feldschuh (Jonathan Adam) holds 35.91K shares, accounting for 0.72% of the total shares.
The Vanguard Group, Inc. holds 49.03K shares, accounting for 0.98% of the total shares.
Renaissance Technologies LLC holds 28.02K shares, accounting for 0.56% of the total shares.
What are the top three shareholder types of Daxor Corp?
The top three shareholder types of Daxor Corp are:
Joseph Feldschuh UEO
Feldschuh (Michael Richard)
Feldschuh (Jonathan Adam)
Joseph Feldschuh UEO
Feldschuh (Michael Richard)
Feldschuh (Jonathan Adam)
How many institutions hold shares of Daxor Corp (DXR)?
As of 2025Q4, 14 institutions hold shares of Daxor Corp, with a combined market value of approximately 102.17K, accounting for 2.33% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Daxor Corp?
In --, the -- business generated the highest revenue for Daxor Corp, amounting to -- and accounting for --% of total revenue.
